Abstract
Periprosthetic joint infection in total knee arthroplasty is a significant complication that is a common reason for revision surgery. The current standard of care is two-stage revision surgery. There is however increasing evidence to support the use of single-stage revision surgery. We conducted a PRISMA systematic review of the current evidence on the use of single-stage revision for infected total knee arthroplasty. Four databases (PubMed, Embase, Science Direct, and Cochrane Library) were systematically screened for eligible studies. The risk bias of each study was identified using ROBINS-I tool, and the quality of evidence was assessed using the GRADE criteria. Sixteen articles were retained after applying the inclusion and exclusion criteria that evaluated 3645 knee single-stage revision surgeries. Our review reveals satisfactory outcomes for single-stage revision in the management of infected total knee arthroplasty. The reinfection rates in the studies included in our review varied however the majority reported low reinfection rates and good functional outcomes. Although strict patient selection criteria have yielded successful results, good results were also reported when these criteria were not applied. The greater use of risk factors in identifying patients likely to have a successful outcome needs to be balanced with the practical benefits of performing a single stage procedure in higher risk patients. Future large clinical randomized control trials are required to confirm our results.
1. Introduction
According to the United Kingdom (UK) National Joint Registry (NJR), there have been 1,087,611 total knee arthroplasty (TKA) procedures reported from the 1st of April 2003 till the 31st of December 2017 [1]. The most common indication for surgery was osteoarthritis, accounting for 97% of the cases [1]. Women were more commonly operated on than men, and the mean age at the time of operation was 68.9 years [1]. In the United States (US) alone it is approximated that the need for TKA will substantially increase by 673% equating to 3.48 million procedures by 2030 [2]. Periprosthetic joint infection (PJI) is one of the most dreaded complications of TKA, and is a well-defined reason for revision surgery [3,4]. In a recent study [5], it was concluded that PJI account for 26.8% of revision surgeries. It is approximated that by 2030 $13 billion will be spent annually by the US health system on revision surgeries [2]. Several factors are associated with an increased risk of developing PJI, these include a surgical site infection not involving the joint prosthesis, a National Nosocomial Infections Surveillance (NNIS) System surgical patient risk index score of 1 or 2 and existing malignancy [6].
Various surgical options are available for the management of PJI after a TKA. These include debridement and retention of the prosthetic implants, two-stage exchange revision, single-stage or direct exchange revision, permanent resection arthroplasty, and finally amputation as the last measure [7]. Although debridement and retention of the prosthetic implants is a viable option in the early stages of an acute infection, established infection does necessitate the removal of all prostheses. A large volume of literature reports good outcomes with two-stage revision of with a clearance rate of 90% [8]. The fact that patients undergo two surgeries in two-stage revision increases the chance of eradicating the infection, and provides sufficient time to evaluate the response of the patient to the antibiotics before definitive implants are introduced at the second stage [9]. However, this restricts the patient’s daily activities between the two surgeries when the patient will have a temporary implant, carries the risk of complications associated with the temporary implant and of the two anesthetics, and is associated with a high financial cost [9].
Recently single-stage revision surgery has gained increased popularity in the management of PJIs; it includes only one surgical procedure, and is linked to better outcomes in terms of morbidity, mortality, cost and total duration of the procedure [4,10]. Studies investigating single-stage revision show promising results. The reinfection rate (RR) of single-stage revision surgery (5–25%) [8,11,12,13,14,15,16,17,18] is comparable to two-stage revision (9–20%) [3]. In particular, in a study of 28 highly selected patients undergoing single-stage revision surgery for chronically infected knee arthroplasties, it was shown that patients were free of reinfection after a 3 year follow-up [8]. In another study investigating 50 knee revision surgeries with an average follow-up of 10.5 years, the reinfection rate was reported to be 2% [19]. The evidence supporting single or two-stage approach for PJI is not definitive. The aim of this review is to report the most up-to-date evidence on single-stage revision for infected TKA.
2. Methods
2.1. Literature Search Strategy
This systematic review was conducted according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [20]. A comprehensive search was performed on four medical electronic databases (PubMed, Embase Science Direct, and Cochrane Library) by two independent authors (K.M.Y. and E.C.) from the 1st of January 1998 to the 20th of October 2018. Our main aims were to: (1) determine the reinfection rate after single-stage revision, (2) identify risk factors associated with the main outcome, and (3) evaluate functional outcome through validated scores. To achieve the maximum sensitivity of the search strategy, we combined the terms: ‘‘knee” with “(replacement OR arthroplasty)”, ‘‘knee” with “(single-stage exchange) OR (single-stage revision)” as either key words or MeSH terms. The reference lists of all included articles, previous literature reviews on the topic and top hits from Google Scholar were reviewed for further identification of potentially relevant studies and were assessed using the inclusion and exclusion criteria. In order to avoid overlap with other ongoing reviews, we first searched the PROSPERO site for any similar review and then prospectively registered our study (registration number: CRD42018116838).
2.2. Selection Criteria
Eligible studies for the present systematic review included those investigating the use of single-stage surgery for the revision of infected TKA. Primary screening of the titles and abstracts was performed and all studies of any level of evidence published in peer-reviewed journals reporting clinical results were included. Moreover, articles discussing both single-stage and two-stages were reviewed. Exclusion criteria included studies investigating revision surgeries for non-infective reasons such as aseptic loosening, periprosthetic fractures and persistent pain. Additionally, we excluded studies in which data about single-stage revision was not accessible, missing, without an available full text, or not well reported. We also excluded all duplicates, and studies with poor scientific methodology. All publications were limited to in vivo human studies in the English language. Abstracts, case reports, conference presentations, reviews, editorials and expert opinions were excluded. The study selection was performed independently by two authors (K.M.Y. and E.C.), and any discrepancies in the selection process were resolved by discussion amongst the authors. A senior investigator (W.S.K.) was consulted to revise the selection process.
2.3. Data Extraction and Criteria Appraisal
All data was extracted from article texts, tables and figures. Data was extracted using the Population, Intervention, Comparison, Outcome (PICO) framework and included title, year of publication, study design, sample size, study population, patient characteristics, intervention and comparator (where applicable), outcomes, funding and conclusions. Two investigators independently reviewed each article (K.M.Y. and E.C.). Discrepancies between the two reviewers were resolved by discussion and consensus. The final results were reviewed by the senior investigator (W.S.K.).
2.4. Risk of Bias Assessment
Risk of bias assessment of all in vivo selected full-text articles was performed according to the ROBINS-I tool for non-randomized studies [21] (Supplementary Materials Table S1). This assessment used “Low,” “Moderate,” and “High” as judgement keys: “Low” indicated a low risk of bias, “moderate” indicated that the risk of bias was moderate, and “High” indicated a high risk of bias. The assessment was performed by two authors (K.M.Y. and E.C.) independently. Inter-rater agreement was 92%. Any discrepancy was discussed with the senior investigator (W.S.K.) for the final decision.
2.5. Study Quality Assessment
The quality of evidence and risk of bias were assessed using the Grading Recommendations Assessment and Development Evidence (GRADE) criteria with supporting guidance from the Cochrane website [22]. The GRADE approach considers five elements, namely, risk of bias, imprecision, inconsistency, indirectness, and publication bias, for downgrading the overall quality of evidence. We presented the main findings of the review in a tabular format (Supplementary Materials Table S2). Results are reported as “Very low”: the true effect is probably markedly different from the estimated effect, “Low”: the true effect might be markedly different from the estimated effect, “Moderate”: the authors believe that the true effect is probably close to the estimated effect, and “High”: the authors have a lot of confidence that the true effect is similar to the estimated effect. The assessment was performed by two authors (K.M.Y. and E.C.) independently. The inter-rater agreement was 94%. Any discrepancy was discussed with the senior investigator (W.S.K.) for the final decision.
2.6. Statistical Methods and Analysis
All statistical analyses were performed with SPSS software (version 17.0; IBM, Armonk, NY, USA). Quantitative variables were presented as mean and standard deviation. We analyzed the correlation between the quantitative variables extracted from the included studies and the reinfection rate. In order to assess the influence of the quality of the studies included on the reinfection rate outcome we used the Welch independent sample t test because of the unequal distribution of the samples. Differences with p < 0.05 were considered statistically significant. Due to the heterogenous nature of the studies and the lack of controlled studies, it was not possible to perform a metanalysis and descriptive synthesis was undertaken.
3. Results
3.1. Study Selection
A total of n = 222 studies was collected from the databases using the aforementioned inclusion and exclusion criteria. Overall n = 112 papers were screened through abstract and title reading after the removal of the duplicates. Ultimately, after reading the full texts and checking the reference lists, we selected n = 16 articles for analyses in our systematic review. A PRISMA [20] flow chart of the selection process and screening is provided in Figure 1.
Figure 1.
PRISMA flowchart of the systematic literature review.
3.2. Study Characteristics
Of the sixteen included studies [8,11,12,13,14,15,16,17,18,19,21,22,23,24,25,26] that met the inclusion criteria, thirteen were retrospective studies [8,11,12,13,14,15,16,17,21,22,23,24,25]; nine were retrospective cohort studies [8,11,12,15,17,22,23,24,25], one was a retrospective case series [21], one was a retrospective descriptive study [16], one was a case-control study [13], and one was a large retrospective observational database study [14]. Three were prospective studies [18,19,26]; two prospective cohort studies [19,26], and one prospective observational cohort study [18]. Overall, 3,645 single-stage knee revision surgeries were included in this systematic review. The study design, patient demographics, follow-up, outcomes, and main findings are summarized in Table 1, and the details of the surgical techniques used in each study are included in Table 2.
Table 1.
The main characteristics of the included studies.
Table 2.
Details of the surgical technique carried out in the included studies.
In our review the reinfection rate ranged from 0–38%, with a mean of 15.42% (Median 15.00%, SD ± 10.42). We further evaluated the variability of reinfection rate between high and moderate quality studies. We found a significant (p = 0.003) association between lower reinfection rates and studies assessed as “high quality” (t: –3.551; df: 13.83). The scoring systems used in our included studies were Hospital for Special Surgery [HSS] score, International Knee Society Score [IKS], Knee society Score [KSS], Oxford–12 Knee Score [OKS], and Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] function score. The most commonly used function scores were the KSS (38.5%), followed by OKS (23%) and HSS (23%). In the high-quality studies, the most commonly utilized function scores were KSS followed by OKS, whereas the most commonly used function scores in the moderate quality studies were KSS and HSS.
4. Discussion
Several surgical techniques are available for the management of established PJI in knee arthroplasty and these commonly include a single or two–stage revision. Controversy however exists regarding the use of single–stage revision surgery as some studies in the literature report a higher reinfection rate [3,8,11,12,13,14,15,16,17,18,27]. In this study, we systematically reviewed the available evidence regarding the effectiveness of single–stage revision in infected TKA with a focus on reinfection rate and functional outcome.
4.1. Reinfection Rates
Kunutsor et al. [28] looked at aggregate published data looking at reinfection rate within two years of revision for single–stage and two–stage revision knee surgery. They found both approaches to be effective in treating infected knee prostheses in generally unselected patients with reinfection rates of 7.6% (3.4–13.1%) in single–stage studies and 8.8% (7.2–10.6%) in two–stage revision. The largest study [14] reporting on single–stage revision surgery included in our review investigated 3069 patients through the Medicare registry in the United States. The reinfection rate for single–stage revision surgery was reported to be 24.6% and 38.25% at 1 year and 6 years respectively. This was higher than the reinfection rate for two–stage revision surgery reported as 19% and 29% at 1 year and 6 years respectively. The Medicare registry is a large national database in the United States and invariably includes a heterogenous mix of patients with a wide range of risk factors. This highlights the regional variation in surgical practices and outcomes.
When analyzing the reinfection rate (%) against the quality of our included studies (Figure 2) we observed a lower, yet wider range of reinfection rates in the high quality studies when compared to the moderate quality studies. This translated into a significant difference (P = 0.003) in reinfection rate outcome between the high and moderate quality studies (Figure 3).
Figure 2.
Reinfection rate (%) reported against the quality of the included studies.
Figure 3.
Welch t–student test distribution plot of reinfection rate (%) against the quality of the included studies.
This difference could be explained by the stronger methodology standards utilized in the studies assessed as “high quality” compared to the studies assessed as “moderate quality”. A well–structured methodology plays a substantial role in producing more accurate and reliable result, which leads to a stronger conclusion that is clinically relevant. In addition, we found that 50% of the moderate quality studies did not describe their surgical procedure used in the single–stage revision. In addition, our review did not reveal any significant difference in the age of the patients, and follow–up duration between the high and moderate quality studies that could account for the considerable differences noted in the reinfection rates.
4.2. Risk Factors for Reinfection
Although a high reinfection rate of 23% was noted by Massin et al. [15] in a population with an average age of 71 years, Kunutsor et al. [28] and Cochran et al. [14] reported no significant association between age and developing reinfection after revision of infected total knee arthroplasty.
High reinfection rates have been associated with obstructive sleep apnea (OSA) and body mass index (BMI) > 30 kg/m2 [11,13]. Although Cochran et al. [14] did not report on the BMI status of the patients due to concerns over completeness and accuracy of data, a high BMI is another significant risk factor in developing reinfections owing to the prolonged procedure duration, comorbidities, and poor delivery of the antibiotic to the surrounding tissues [29,30,31].
Previous joint surgeries was also reported as risk factor for developing recurrent infections in a number of studies [28,32,33]. In a study [16] comparing recurrence of infection between primary total knee arthroplasty prosthesis and rotating hinged prosthesis, it was shown that rate of infection recurrence was 0% and 15% respectively. None of the primary total knee arthroplasty prosthesis group had previous surgery whereas 30% of the hinge prostheses patients had previous septic revisions. Also, 35% of the group with the hinge prosthesis had a fistula compared to 5.4% in the primary total knee arthroplasty prosthesis. Klatte et al. [24] reported one case of revision for recurrent infection out of 4 patients with hinged prostheses; the recurrent infection was immunocompromised due to prolonged steroid use and has diabetes.
Other risk factors associated with developing reinfection after a single–stage revision surgery include a history of diabetes, rheumatoid arthritis, smoking, depression and previous steroid use [28]. In a study [19] investigating single–stage revision surgery on 50 knees it was concluded that rheumatoid arthritis patients have a twenty–fold higher odds of death than osteoarthritis (p = 0.04). Massin et al. [15] identified other factors associated with infection recurrence including fistulae, infection by gram–negative bacteria, and two–stage surgery with static spacers. Although Staphylococcus aureus is a common organism in PJI [8,14,22], failure rates in single–stage revision surgeries are considerably higher in patients with fungal infections despite following a strict antifungal and antibiotic regimen [21,24].
4.3. Functional Outcomes
Although all of the included studies in our review reported successful outcomes following single–stage revision [8,13,15,16,17,18,19,21,22,23,24,25,26], heterogeneity of the reported functional outcome scores meant that it was not possible to perform a meaningful statistical comparison. Singer et al. [16] concluded that the KSS postoperatively in single–stage revision was higher than that reported for two–stage revision. Additionally, the KSS was significantly (p < 0.02) higher in single–stage revision surgery patients compared to two–stage revision patients as reported by Haddad et al. [8]. Ji et al. [21] showed a significant improvement in HSS score postoperatively in patients managed for fungus infected knee prosthesis. Klatte et al. [24] also noted the mean HSS knee score to significantly increase from 51 to 75. Significant postoperative improvements in OKS were reported by three studies [16,19,26].
4.4. Patient Selection Criteria
Recent evidence suggests that single–stage revision surgery is a viable option in the management of infected TKA [8,11,12,16,18,19,25,27]. Surgeon preference and strict patient selection criteria can influence the rate of success of single–stage revision surgery [8,11,18,21]. Haddad et al. [8] and Li et al. [12] reported a reinfection rate of 0% in 28 PJIs and 9.09% in 22 PJIs respectively when applying a strict selection protocol. Li et al. [12] reported a success rate of 90.9% in patients undergoing single–stage revision surgery, and attributed the results to the fact that their patients underwent the procedure only if there was a positive response to the antibiotic treatment. In addition, antibiotics were commenced in accordance to the drug sensitivity test, which allows for more specified microorganism targeting and decreases the chance of antibiotic resistance. Jenny et al. [13] investigated 131 patients that underwent single–stage revision surgery and found no significant difference in reinfection rates when comparing a study group (n = 54) with no strict selection criteria with a control group (n = 77) with a strict selection criteria. Zahar et al. [23] investigated 46 patients and concluded that the 10–year infection–free survival rate was 93% despite not adhering to a strict selection criteria protocol, however in this study the specific patient demographics and comorbidities were not reported. These conflicting results highlight the need for more work to be done to better define the role of selection criteria in deciding suitability for single–stage revision surgery.
Risk factors including immunosuppression, rheumatoid arthritis and malignancy are associated with increased perioperative complications, and warrant consideration [22,32,33]. Comorbidities increase the risk of reinfection, and patients with significant comorbidities have historically been managed with a two–stage revision. There is an argument for managing these patients with a single–stage procedure avoiding the need for two general anesthetics and the morbidities associated with an interim spacer between the two surgeries [32,34].
5. Limitations
The major limitation of this systematic review is the quality of the included studies. Most of the included studies are retrospective, with no clinical randomized controlled trials identified. Despite applying a specific time frame for our review, the management preference and infecting organisms have varied during this timeframe. We do however believe that this work summarizes and highlights the relevant evidence in the literature that would help guide clinical randomized controlled trials.
6. Conclusions
This study is the first PRISMA review of single-stage knee revision surgery for PJI to our knowledge. Our review reveals satisfactory outcomes for single-stage revision in the management of infected total knee arthroplasty. The reinfection rates in the studies included in our review varied however the majority reported low reinfection rates and good functional outcomes. Although strict patient selection criteria have yielded successful results, good results were also reported when these criteria were not applied. The greater use of risk factors in identifying patients likely to have a successful outcome needs to be balanced with the practical benefits of performing a single stage procedure in higher risk patients. Data from joint registries is useful but the heterogeneous nature of the cases makes interpretation difficult. Future good quality large clinical randomized control trials are needed to confirm our results and allow for more objective analysis of the surgical technique and success rate.
Supplementary Materials
The following are available online at http://www.mdpi.com/2077-0383/8/2/174/s1, Table S1: Appendix A—Risk of Bias; Table S2: Appendix B—GRADE Quality.
Author Contributions
Conceptualization, W.S.K.; methodology, K.M.Y., E.C. and W.S.K.; software, K.M.Y. and E.C.; validation, K.M.Y. and E.C.; formal analysis, K.M.Y. and E.C.; investigation, K.M.Y. and E.C.; resources, K.M.Y., E.C. and W.S.K.; data curation, K.M.Y. and E.C.; writing—original draft preparation, K.M.Y. and E.C.; writing—review and editing, K.M.Y., E.C. and W.S.K.; visualization, W.S.K.; supervision, W.S.K.; project administration, W.S.K.; funding acquisition, W.S.K.
Conflicts of Interest
The authors declare no conflict of interest.
References
- National Joint Registry. Available online: http://www.njrreports.org.uk/Portals/0/PDFdownloads/NJR%2015th%20Annual%20Report%202018.pdf (accessed on 2 November 2018).
- Kurtz, S.; Ong, K.; Lau, E.; Mowat, F.; Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Jt. Surg. Am. 2007, 89, 780–785. [Google Scholar]
- Kunutsor, S.K.; Whitehouse, M.R.; Blom, A.W.; Beswick, A.D.; INFORM Team. Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. PLoS ONE 2016, 11, e0150866. [Google Scholar] [CrossRef] [Scilit]
- Rowan, F.E.; Donaldson, M.J.; Pietrzak, J.R.; Haddad, F.S. The Role of One-Stage Exchange for Prosthetic Joint Infection. Curr. Rev. Musculoskelet. Med. 2018, 11, 370–379. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Thiele, K.; Perka, C.; Matziolis, G.; Mayr, H.O.; Sostheim, M.; Hube, R. Current failure mechanisms after knee arthroplasty have changed: Polyethylene wear is less common in revision surgery. J. Bone Jt. Surg. Am. 2015, 97, 715–720. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pan, A.; Cauda, R.; Concia, E.; Esposito, S.; Sganga, G.; Stefani, S.; Nicastri, E.; Lauria, F.N.; Carosi, G.; Moroni, M.; et al. Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections. Int. J. Infect. Dis. 2010, 14, 39–53. [Google Scholar] [CrossRef] [Scilit]
- Osmon, D.R.; Berbari, E.F.; Berendt, A.R.; Lew, D.; Zimmerli, W.; Steckelberg, J.M.; Rao, N.; Hanssen, A.; Wilson, W.R.; Infectious Diseases Society of America. Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2013, 56, 1–25. [Google Scholar] [CrossRef] [Scilit]
- Haddad, F.S.; Sukeik, M.; Alazzawi, S. Is Single-stage Revision According to a Strict Protocol Effective in Treatment of Chronic Knee Arthroplasty Infections? Clin. Orthop. Relat. Res. 2015, 473, 8–14. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Negus, J.J.; Gifford, P.B.; Haddad, F.S. Single-Stage Revision Arthroplasty for Infection—An Underutilized Treatment Strategy. J. Arthroplast. 2017, 32, 2051–2055. [Google Scholar] [CrossRef] [Scilit]
- Belden, K.; Cao, L.; Chen, J.; Deng, T.; Fu, J.; Guan, H.; Jia, C.; Kong, X.; Kuo, F.C.; Li, R.; et al. Hip and Knee Section, Fungal Periprosthetic Joint Infection, Diagnosis and Treatment: Proceedings of International Consensus on Orthopedic Infections. J. Arthroplast. 2019, 34, S387–S391. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Castellani, L.; Daneman, N.; Mubareka, S.; Jenkinson, R. Factors Associated with Choice and Success of One- Versus Two-Stage Revision Arthroplasty for Infected Hip and Knee Prostheses. HSS J. 2017, 13, 224–231. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Li, H.; Ni, M.; Li, X.X.; Zhang, Q.; Li, X.X.; Chen, J. Two-stage revisions for culture-negative infected total knee arthroplasties: A five-year outcome in comparison with one-stage and two-stage revisions for culture-positive cases. J. Orthop. Sci. 2017, 22, 306–312. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jenny, J.Y.; Barbe, B.; Cazenave, A.; Roche, O.; Massin, P. Patient selection does not improve the success rate of infected TKA one stage exchange. Knee 2016, 23, 1012–1015. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cochran, A.R.; Ong, K.L.; Lau, E.; Mont, M.A.; Malkani, A.L. Risk of Reinfection After Treatment of Infected Total Knee Arthroplasty. J. Arthroplast. 2016, 31, 156–161. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Massin, P.; Delory, T.; Lhotellier, L.; Pasquier, G.; Roche, O.; Cazenave, A.; Estellat, C.; Jenny, J.Y. Infection recurrence factors in one- and two-stage total knee prosthesis exchanges. Knee Surg. Sport Traumatol. Arthrosc. 2016, 24, 3131–3139. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Singer, J.; Merz, A.; Frommelt, L.; Fink, B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin. Orthop. Relat. Res. 2012, 470, 1461–1471. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shanmugasundaram, S.; Ricciardi, B.F.; Briggs, T.W.R.; Sussmann, P.S.; Bostrom, M.P. Evaluation and Management of Periprosthetic Joint Infection-an International, Multicenter Study. HSS J. 2014, 10, 36–44. [Google Scholar] [CrossRef] [Scilit]
- Jenny, J.Y.; Barbe, B.; Gaudias, J.; Boeri, C.; Argenson, J.N. High infection control rate and function after routine one-stage exchange for chronically infected TKA. Clin. Orthop. Relat. Res. 2013, 471, 238–243. [Google Scholar] [CrossRef] [Scilit]
- Tibrewal, S.; Malagelada, F.; Jeyaseelan, L.; Posch, F.; Scott, G. Single-stage revision for the infected total knee replacement: Results from a single centre. Bone Jt. J. 2014, 96, 759–764. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009, 339, 1–27. [Google Scholar] [CrossRef] [Scilit]
- Ji, B.; Zhang, X.; Xu, B.; Guo, W.; Mu, W.; Cao, L. Single-Stage Revision for Chronic Fungal Periprosthetic Joint Infection: An Average of 5 Years of Follow-Up. J. Arthroplast. 2017, 32, 2523–2530. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- de Paula Leite Cury, R.; Cinagawa, E.H.T.; Camargo, O.P.A.; Honda, E.K.; Klautau, G.B.; Salles, M.J.C. Treatment of infection after total knee arthroplasty. Acta Ortopédica Bras. 2015, 23, 239–243. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zahar, A.; Kendoff, D.O.; Klatte, T.O.; Gehrke, T.A. Can Good Infection Control Be Obtained in One-stage Exchange of the Infected TKA to a Rotating Hinge Design? 10–year Results. Clin. Orthop. Relat. Res. 2016, 474, 81–87. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Klatte, T.O.; Kendoff, D.; Kamath, A.F.; Jonen, V.; Rueger, J.M.; Frommelt, L.; Gebauer, M.; Gehrke, T. Single-stage revision for fungal peri-prosthetic joint infection. Bone Jt. J. 2014, 96, 492–496. [Google Scholar] [CrossRef] [Scilit]
- Whiteside, L.A.; Peppers, M.; Nayfeh, T.A.; Roy, M.E. Methicillin-resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin. Orthop. Relat. Res. 2011, 469, 26–33. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Baker, P.; Petheram, T.G.; Kurtz, S.; Konttinen, Y.T.; Gregg, P.; Deehan, D. Patient reported outcome measures after revision of the infected TKR: Comparison of single versus two-stage revision. Knee Surg. Sport Traumatol. Arthrosc. 2013, 21, 2713–2720. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bialecki, J.; Bucsi, L.; Fernando, N.; Foguet, P.; Guo, S.; Haddad, F.; Hansen, E.; Janvari, K.; Jones, S.; Keogh, P.; et al. Hip and Knee Section, Treatment, One Stage Exchange: Proceedings of International Consensus on Orthopedic Infections. J. Arthroplast. 2019, 34, S421–S426. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kunutsor, S.K.; Whitehouse, M.R.; Lenguerrand, E.; Blom, A.W.; Beswick, A.D.; INFORM Team. Re-infection outcomes following one-and two-stage surgical revision of infected knee prosthesis: A systematic review and meta-analysis. PLoS ONE 2016, 11, e0151537. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dowsey, M.M.; Choong, P.F.M. Obese Diabetic Patients are at Substantial Risk for Deep Infection after Primary TKA. Clin. Orthop. Relat. Res. 2009, 467, 1577–1581. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liabaud, B.; Patrick, D.A., Jr.; Geller, J.A. Higher Body Mass Index Leads to Longer Operative Time in Total Knee Arthroplasty. J. Arthroplast. 2013, 28, 563–565. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Toma, O.; Suntrup, P.; Stefanescu, A.; London, A.; Mutch, M.; Kharasch, E. Pharmacokinetics and tissue penetration of cefoxitin in obesity: Implications for risk of surgical site infection. Anesth. Analg. 2011, 113, 730–737. [Google Scholar] [CrossRef] [Scilit]
- Fehring, K.A.; Abdel, M.P.; Ollivier, M.; Mabry, T.M.; Hanssen, A.D. Repeat two-stage exchange arthroplasty for periprosthetic knee infection is dependent on host grade. J. Bone Jt. Surg. Am. 2017, 99, 19–24. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kurtz, S.M.; Ong, K.L.; Lau, E.; Bozic, K.J.; Berry, D.; Parvizi, J. Prosthetic Joint Infection Risk after TKA in the Medicare Population. Clin. Orthop. Relat. Res. 2010, 468, 52–56. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ji, B.; Zhang, X.; Xu, B.; Ren, J.; Guo, W.; Mu, W.; Cao, L. The fate of immunocompromised patients in the treatment of chronic periprosthetic joint infection: A single-centre experience. Int. Orthop. 2018, 42, 487–498. [Google Scholar] [CrossRef] [Scilit] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).


